FR06C0032I1 - - Google Patents
Info
- Publication number
- FR06C0032I1 FR06C0032I1 FR06C0032C FR06C0032I1 FR 06C0032 I1 FR06C0032 I1 FR 06C0032I1 FR 06C0032 C FR06C0032 C FR 06C0032C FR 06C0032 I1 FR06C0032 I1 FR 06C0032I1
- Authority
- FR
- France
- Prior art keywords
- pharmaceutical formulations
- osteoporosis
- useful
- concentration
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 101001135770 Homo sapiens Parathyroid hormone Proteins 0.000 abstract 1
- 101001135995 Homo sapiens Probable peptidyl-tRNA hydrolase Proteins 0.000 abstract 1
- 208000001132 Osteoporosis Diseases 0.000 abstract 1
- 210000000988 bone and bone Anatomy 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 102000058004 human PTH Human genes 0.000 abstract 1
- 239000008181 tonicity modifier Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Endocrinology (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9801495A SE9801495D0 (sv) | 1998-04-28 | 1998-04-28 | Protein formulationa |
| PCT/CA1999/000376 WO1999055353A2 (en) | 1998-04-28 | 1999-04-26 | Protein formulations |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR06C0032I1 true FR06C0032I1 (ja) | 2006-11-24 |
| FR06C0032I2 FR06C0032I2 (fr) | 2007-04-27 |
Family
ID=20411122
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR06C0032C Active FR06C0032I2 (fr) | 1998-04-28 | 2006-10-20 | Formulations proteiniques |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US20050209144A1 (ja) |
| EP (1) | EP1079803B1 (ja) |
| JP (2) | JP4733267B2 (ja) |
| KR (1) | KR100579872B1 (ja) |
| CN (1) | CN1172658C (ja) |
| AT (1) | ATE273693T1 (ja) |
| AU (2) | AU766514B2 (ja) |
| BR (1) | BR9909958A (ja) |
| CA (1) | CA2329800C (ja) |
| CY (1) | CY2006006I2 (ja) |
| DE (3) | DE122006000057I1 (ja) |
| DK (1) | DK1079803T3 (ja) |
| ES (1) | ES2224637T3 (ja) |
| FR (1) | FR06C0032I2 (ja) |
| HK (1) | HK1041218B (ja) |
| IL (1) | IL139320A (ja) |
| LU (1) | LU91281I2 (ja) |
| NL (1) | NL300243I2 (ja) |
| NZ (1) | NZ508269A (ja) |
| PT (1) | PT1079803E (ja) |
| SE (1) | SE9801495D0 (ja) |
| SI (1) | SI1079803T1 (ja) |
| WO (1) | WO1999055353A2 (ja) |
| ZA (1) | ZA200006040B (ja) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6770623B1 (en) | 1997-12-09 | 2004-08-03 | Eli Lilly And Company | Stabilized teriparatide solutions |
| SE9801495D0 (sv) * | 1998-04-28 | 1998-04-28 | Astra Ab | Protein formulationa |
| WO2005014034A1 (en) * | 2003-07-14 | 2005-02-17 | Nps Allelix Corp. | Stabilized formulation of parathyroid hormone |
| WO2007059470A2 (en) * | 2005-11-10 | 2007-05-24 | Board Of Control Of Michigan Technological University | Black bear parathyroid hormone and methods of using black bear parathyroid hormone |
| USRE49444E1 (en) | 2006-10-03 | 2023-03-07 | Radius Health, Inc. | Method of treating osteoporosis comprising administration of PTHrP analog |
| US7803770B2 (en) | 2006-10-03 | 2010-09-28 | Radius Health, Inc. | Method of treating osteoporosis comprising administration of PTHrP analog |
| MX2009003569A (es) | 2006-10-03 | 2009-08-25 | Radius Health Inc | Metodo de administracion de farmacos para la proteina anabolica osea. |
| FR2925333B1 (fr) * | 2007-12-19 | 2012-04-13 | Farid Bennis | Compositions pharmaceutiques renfermant au moins un principe actif proteinique protege des enzymes digestives |
| JP2009091363A (ja) * | 2008-11-21 | 2009-04-30 | Asahi Kasei Pharma Kk | Ｐｔｈの安定化水溶液注射剤 |
| JP2013512688A (ja) | 2009-12-07 | 2013-04-18 | ミシガン テクノロジカル ユニバーシティ | クロクマの副甲状腺ホルモン及びクロクマの副甲状腺ホルモンを使用する方法 |
| CN103561757B (zh) | 2011-06-07 | 2016-01-06 | 旭化成制药株式会社 | 高纯度含pth冷冻干燥制剂及其制造方法 |
| CN103301058A (zh) * | 2013-06-17 | 2013-09-18 | 深圳翰宇药业股份有限公司 | 一种特立帕肽注射用组合物及其制备方法和制剂 |
| AU2016256470B2 (en) | 2015-04-29 | 2020-10-15 | Radius Pharmaceuticals, Inc. | Methods of treating cancer |
| CN106309358A (zh) * | 2015-06-29 | 2017-01-11 | 成都金凯生物技术有限公司 | 含有人甲状旁腺激素的药物组合物及其制备方法与用途 |
| LT3565542T (lt) | 2017-01-05 | 2024-07-10 | Radius Pharmaceuticals, Inc. | Polimorfinės rad1901-2hcl formos |
| CN108333360A (zh) * | 2017-01-19 | 2018-07-27 | 深圳市新产业生物医学工程股份有限公司 | 胃泌素释放肽前体稀释液及其应用和试剂盒 |
| US10996208B2 (en) | 2017-04-28 | 2021-05-04 | Radius Health, Inc. | Abaloparatide formulations and methods of testing, storing, modifying, and using same |
| WO2019059302A1 (ja) * | 2017-09-22 | 2019-03-28 | 旭化成ファーマ株式会社 | 安定性に優れるテリパラチド含有液状医薬組成物 |
| CN108159404B (zh) * | 2018-01-05 | 2019-08-27 | 北京博康健基因科技有限公司 | 重组人甲状旁腺激素制剂及其制备方法 |
| CN112423844B (zh) | 2018-07-04 | 2024-08-13 | 雷迪厄斯制药公司 | Rad1901-2hcl的多晶型形式 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5981485A (en) * | 1997-07-14 | 1999-11-09 | Genentech, Inc. | Human growth hormone aqueous formulation |
| DE3935738A1 (de) * | 1989-10-27 | 1991-05-08 | Forssmann Wolf Georg | Arzneimittel, enthaltend das humane parathormon-fragment (1-37) als aktiven wirkstoff |
| US5744444A (en) * | 1989-10-27 | 1998-04-28 | Haemopep Pharma Gmbh | HPTH-fragment-(1-37), the preparation thereof, medicaments containing same and the use thereof |
| US5547939A (en) * | 1991-06-14 | 1996-08-20 | The Regents Of The University Of California | Broad spectrum antimicrobial compounds and methods of use |
| JP2662842B2 (ja) * | 1991-12-09 | 1997-10-15 | 旭化成工業株式会社 | パラサイロイドホルモンの安定化組成物 |
| KR0131678B1 (ko) * | 1991-12-09 | 1998-04-17 | 유미꾸라 레이이찌 | 파라티로이드 호르몬류의 안정화 조성물 |
| EP0679088B1 (en) * | 1992-09-29 | 2002-07-10 | Inhale Therapeutic Systems | Pulmonary delivery of active fragments of parathyroid hormone |
| US5496801A (en) * | 1993-12-23 | 1996-03-05 | Allelix Biopharmaceuticals Inc. | Parathyroid hormone formulation |
| JPH09157294A (ja) * | 1995-06-15 | 1997-06-17 | Takeda Chem Ind Ltd | 副甲状腺ホルモン誘導体 |
| DE19538687A1 (de) * | 1995-10-17 | 1997-04-24 | Boehringer Mannheim Gmbh | Stabile pharmazeutische Darreichungsformen enthaltend Parathormon |
| JP4053107B2 (ja) * | 1996-02-01 | 2008-02-27 | 中外製薬株式会社 | 血小板減少症の予防剤および治療剤 |
| US5964807A (en) * | 1996-08-08 | 1999-10-12 | Trustees Of The University Of Pennsylvania | Compositions and methods for intervertebral disc reformation |
| DE19733651A1 (de) * | 1997-08-04 | 1999-02-18 | Boehringer Ingelheim Pharma | Wässrige Aerosolzubereitungen enthaltend biologisch aktive Markomoleküle und Verfahren zur Erzeugung entsprechender Aerosole |
| SE9801495D0 (sv) * | 1998-04-28 | 1998-04-28 | Astra Ab | Protein formulationa |
-
1998
- 1998-04-28 SE SE9801495A patent/SE9801495D0/xx unknown
-
1999
- 1999-04-26 WO PCT/CA1999/000376 patent/WO1999055353A2/en active IP Right Grant
- 1999-04-26 BR BR9909958-6A patent/BR9909958A/pt not_active Application Discontinuation
- 1999-04-26 DE DE1999619533 patent/DE122006000057I1/de active Pending
- 1999-04-26 IL IL139320A patent/IL139320A/en not_active IP Right Cessation
- 1999-04-26 AU AU35916/99A patent/AU766514B2/en not_active Expired
- 1999-04-26 EP EP99917715A patent/EP1079803B1/en not_active Expired - Lifetime
- 1999-04-26 CN CNB998073628A patent/CN1172658C/zh not_active Expired - Lifetime
- 1999-04-26 AT AT99917715T patent/ATE273693T1/de active
- 1999-04-26 DE DE122006000057C patent/DE122006000057I2/de active Active
- 1999-04-26 ES ES99917715T patent/ES2224637T3/es not_active Expired - Lifetime
- 1999-04-26 DK DK99917715T patent/DK1079803T3/da active
- 1999-04-26 PT PT99917715T patent/PT1079803E/pt unknown
- 1999-04-26 NZ NZ508269A patent/NZ508269A/en not_active IP Right Cessation
- 1999-04-26 DE DE69919533T patent/DE69919533T2/de not_active Expired - Lifetime
- 1999-04-26 CA CA002329800A patent/CA2329800C/en not_active Expired - Lifetime
- 1999-04-26 KR KR1020007012037A patent/KR100579872B1/ko not_active IP Right Cessation
- 1999-04-26 JP JP2000545551A patent/JP4733267B2/ja not_active Expired - Lifetime
- 1999-04-26 SI SI9930678T patent/SI1079803T1/xx unknown
-
2000
- 2000-10-26 ZA ZA200006040A patent/ZA200006040B/en unknown
-
2002
- 2002-04-19 HK HK02102980.6A patent/HK1041218B/zh not_active IP Right Cessation
-
2004
- 2004-01-16 AU AU2004200156A patent/AU2004200156B2/en not_active Expired
- 2004-11-30 US US10/999,160 patent/US20050209144A1/en not_active Abandoned
-
2006
- 2006-10-17 NL NL300243C patent/NL300243I2/nl unknown
- 2006-10-19 LU LU91281C patent/LU91281I2/fr unknown
- 2006-10-20 FR FR06C0032C patent/FR06C0032I2/fr active Active
- 2006-10-23 CY CY200600006C patent/CY2006006I2/el unknown
-
2011
- 2011-01-24 JP JP2011011811A patent/JP5753692B2/ja not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR06C0032I1 (ja) | ||
| YU83502A (sh) | Nova farmaceutska smeša | |
| BG104727A (en) | Pharmaceutical composition of topiramate | |
| BR0008059A (pt) | Composições de valdecoxib | |
| MX9709238A (es) | Formulaciones farmaceuticas y de dieta para la profilaxis y tratamiento de trastornos gastrointestinales. | |
| PL309693A1 (en) | Combined osteoporosis inhibiting treatment | |
| AP9801269A0 (en) | Prostaglandin agonists. | |
| MY118526A (en) | Method for improving the pharmacokinetics of tipranavir | |
| EP1032556A4 (en) | PHARMACEUTICALLY EFFECTIVE COMPOUNDS AND METHODS OF THEIR APPLICATION | |
| HUP0100024A3 (en) | Pharmaceutical compositions for treating alzheimer's disease containing carvedilol as active ingredient | |
| BG102660A (en) | Combined pharmaceutical preparation of lhrh-analogues and antiesterogens for the treatment of gynaecological disorders | |
| BG104179A (en) | Phanquinon administration for the treatment of the alzheimer's disease | |
| UA66932C2 (en) | Complex of eletriptan and sulphobutylether-beta-cyclodextrin, pharmaceutical composition, method for their manufacture and method for treating migraine | |
| IL164317A0 (en) | Statin therapy for enhancing cognitive maintenance | |
| GB9823515D0 (en) | Agent for the treatment of osteoporosis | |
| HUP0100634A2 (hu) | Pentaeritrit-tetranitrátot tartalmazó gyógyászati készítmények | |
| UA30798A (uk) | Спосіб пролонгованої терапії онкологічних хворих | |
| IT1307866B1 (it) | Composizioni farmaceutiche contenenti inibitori dell'ormone dellacrescita o loro frammenti biologicamente attivi per il trattamento | |
| MY118194A (en) | Pharmaceutical compositions for use in inhibiting bone resorption |